Dosage form: tablet
Drug classes:MTOR inhibitors, Selective immunosuppressants
Medically reviewed by Drugs.com. Last updated on Mar 1, 2022.
On This Page
- Indications and Usage
- Dosage and Administration
- Dosage Forms and Strengths
- Contraindications
- Warnings and Precautions
- Adverse Reactions/Side Effects
- Drug Interactions
- Use In Specific Populations
- Description
- Clinical Pharmacology
- Nonclinical Toxicology
- Clinical Studies
- References
- How Supplied/Storage and Handling
- Patient Counseling Information
Indications and Usage for Everolimus Tablets
Hormone Receptor-Positive, HER2-Negative Breast Cancer
Everolimus Tablets are indicated for the treatment of postmenopausal women with advanced hormone receptor-positive, HER2-negative breast cancer in combination with exemestane, after failure of treatment with letrozole or anastrozole.
Tuberous Sclerosis Complex (TSC)-Associated Renal Angiomyolipoma
Everolimus Tablets are indicated for the treatment of adult patients with renal angiomyolipoma and TSC, not requiring immediate surgery.
Tuberous Sclerosis Complex (TSC)-Associated Subependymal Giant Cell Astrocytoma (SEGA)
Everolimus Tablets are indicated in adult and pediatric patients aged 1 year and olde...
